ArticleDiabetes, obesity & metabolism2017

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.

Patrick M O'Neil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.